Filing Details
- Accession Number:
- 0001179110-13-003141
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-20 17:34:35
- Reporting Period:
- 2013-02-15
- Filing Date:
- 2013-02-20
- Accepted Time:
- 2013-02-20 17:34:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1800 | Abbott Laboratories | ABT | Pharmaceutical Preparations (2834) | 360698440 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1298968 | C John Landgraf | 100 Abbott Park Road Abbott Park IL 60064-6400 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares Without Par Value | Acquisiton | 2013-02-15 | 31,700 | $0.00 | 130,174 | No | 4 | A | Direct | |
Common Shares Without Par Value | Disposition | 2013-02-19 | 8,616 | $35.08 | 121,558 | No | 4 | F | Direct | |
Common Shares Without Par Value | Disposition | 2013-02-19 | 2,800 | $34.78 | 118,758 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2013-02-19 | 266 | $34.78 | 118,492 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares | Option (right to buy) | Acquisiton | 2013-02-15 | 165,000 | $0.00 | 165,000 | $34.94 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
165,000 | 2014-02-15 | 2023-02-14 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Shares Without Par Value | 18,257 | Indirect | Profit Sharing Trust |
Common Shares Without Par Value | 11,614 | Indirect | Anne Marie Landgraf Living Trust |
Footnotes
- These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
- Balance in the Abbott Laboratories Stock Retirement Trust as of February 15, 2013.
- Held in the Anne Marie Landgraf Living Trust. The reporting person and his spouse are co-trustees of the trust. The trust is revocable by his spouse.
- Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 55,000 on 2/15/2014, 55,000 on 2/15/2015, and 55,000 on 2/15/2016.